Selank & Semax: Neuropeptides in Cognitive Research
Selank and Semax are synthetic neuropeptides developed in Russia with a focus on anxiolytic and nootropic properties. This article reviews their mechanisms of action and the preclinical evidence supporting their neurological effects.
Overview
Selank and Semax are two of the most extensively studied synthetic neuropeptides, both originating from Russian academic and pharmaceutical research. While structurally distinct, they share an interest as research tools for studying anxiety, cognition, and neuroprotection.
Selank: An Anxiolytic Neuropeptide
Selank is a heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) derived from the sequence of the human immunoglobulin G and tuftsin. It was developed at the Institute of Molecular Genetics of the Russian Academy of Sciences.
Mechanisms of Action
- GABAergic modulation: Research suggests interaction with GABA-A receptors, which may underpin anxiolytic effects observed in animal models
- BDNF upregulation: Preclinical studies showed increased brain-derived neurotrophic factor (BDNF) expression
- Enkephalin metabolism: Selank appears to inhibit enzymes that degrade enkephalins, endogenous opioid peptides involved in stress regulation
Semax: A Cognitive Research Peptide
Semax is a synthetic heptapeptide based on a fragment of ACTH (4-7) with a C-terminal Pro-Gly-Pro extension. It is registered as a drug in Russia for neurological applications.
Mechanisms of Action
- BDNF and NGF upregulation: Multiple studies show increased neurotrophic factor expression
- Dopaminergic and serotonergic activity: Modulation of monoamine systems in the prefrontal cortex
- Neuroprotection: Animal models of stroke and brain injury have shown reduced neuronal death with Semax treatment
Comparative Research Profile
| Feature | Selank | Semax | |---|---|---| | Primary effect | Anxiolytic | Cognitive enhancement | | Origin peptide | Tuftsin | ACTH fragment | | Key mechanism | GABAergic, enkephalins | BDNF/NGF, monoamines |
Research Considerations
Both peptides are typically administered intranasally in research due to poor oral bioavailability. The nasal route allows for direct transport along olfactory pathways. Stability in solution requires careful handling and storage at low temperatures.
Conclusion
Selank and Semax offer complementary research profiles for studying neuropeptide effects on anxiety, cognition, and neuroplasticity. Their established preclinical literature makes them valuable tools for neuroscience researchers.
Research Disclaimer
This article is intended for educational and research purposes only. All products referenced are for laboratory research use only and are not approved for human or animal consumption. PeptidXs does not provide medical advice.
